Cargando…

一种快速检测UGT1A1(*)28基因多态性的方法

BACKGROUND AND OBJECTIVE: Uridine-diphosphoglucuronosyl transferase 1A1 (UGT1A1), UGT1A1(*)28 polymorphism can reduce UGT1A1 enzymatic activity, which may lead to severe toxicities in patients who receive irinotecan. This study tries to build a fragment analysis method to detect UGT1A1(*)28 polymorp...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973388/
https://www.ncbi.nlm.nih.gov/pubmed/29277179
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.12.04
_version_ 1783326618334265344
collection PubMed
description BACKGROUND AND OBJECTIVE: Uridine-diphosphoglucuronosyl transferase 1A1 (UGT1A1), UGT1A1(*)28 polymorphism can reduce UGT1A1 enzymatic activity, which may lead to severe toxicities in patients who receive irinotecan. This study tries to build a fragment analysis method to detect UGT1A1(*)28 polymorphism. METHODS: A total of 286 blood specimens from the lung cancer patients who were hospitalized in Guangdong General Hospital between April 2014 to May 2015 were detected UGT1A1(*)28 polymorphism by fragment analysis method. RESULTS: Comparing with Sanger sequencing, precision and accuracy of the fragment analysis method were 100%. Of the 286 patients, 236 (82.5% harbored TA6/6 genotype, 48 (16.8%) TA 6/7 genotype and 2 (0.7%) TA7/7 genotype. CONCLUSION: Our data suggest hat the fragment analysis method is robust for detecting UGT1A1(*)28 polymorphism in clinical practice. It's simple, time-saving, and easy-to-carry.
format Online
Article
Text
id pubmed-5973388
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59733882018-07-06 一种快速检测UGT1A1(*)28基因多态性的方法 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Uridine-diphosphoglucuronosyl transferase 1A1 (UGT1A1), UGT1A1(*)28 polymorphism can reduce UGT1A1 enzymatic activity, which may lead to severe toxicities in patients who receive irinotecan. This study tries to build a fragment analysis method to detect UGT1A1(*)28 polymorphism. METHODS: A total of 286 blood specimens from the lung cancer patients who were hospitalized in Guangdong General Hospital between April 2014 to May 2015 were detected UGT1A1(*)28 polymorphism by fragment analysis method. RESULTS: Comparing with Sanger sequencing, precision and accuracy of the fragment analysis method were 100%. Of the 286 patients, 236 (82.5% harbored TA6/6 genotype, 48 (16.8%) TA 6/7 genotype and 2 (0.7%) TA7/7 genotype. CONCLUSION: Our data suggest hat the fragment analysis method is robust for detecting UGT1A1(*)28 polymorphism in clinical practice. It's simple, time-saving, and easy-to-carry. 中国肺癌杂志编辑部 2017-12-20 /pmc/articles/PMC5973388/ /pubmed/29277179 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.12.04 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
一种快速检测UGT1A1(*)28基因多态性的方法
title 一种快速检测UGT1A1(*)28基因多态性的方法
title_full 一种快速检测UGT1A1(*)28基因多态性的方法
title_fullStr 一种快速检测UGT1A1(*)28基因多态性的方法
title_full_unstemmed 一种快速检测UGT1A1(*)28基因多态性的方法
title_short 一种快速检测UGT1A1(*)28基因多态性的方法
title_sort 一种快速检测ugt1a1(*)28基因多态性的方法
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973388/
https://www.ncbi.nlm.nih.gov/pubmed/29277179
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.12.04
work_keys_str_mv AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ
AT yīzhǒngkuàisùjiǎncèugt1a128jīyīnduōtàixìngdefāngfǎ